Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 21.78 Delayed Data As of Jun 09 |  -0.16 / -0.73%Today’s Change | 15.10 Today|||52-Week Range 30.22 | -6.12% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 70.2M | 73.4M | 74.5M | 75.0M | |
| Cost of Goods Sold | 13.4M | 13.9M | 45.3M | 44.8M | ||
| Depreciation And Amortization | 32.6M | 15.8M | 3.9M | 3.9M | ||
| Operating Expenses | Gross Income | 24.2M | 43.7M | 25.4M | 26.4M | |
| General Expenses | 35.4M | 32.7M | 35.3M | 31.4M | ||
| Research And Development | 1.9M | 2.2M | 3.0M | 2.5M | ||
| Total Operating Expenses | 81.4M | 62.4M | 84.5M | 80.0M | ||
| Non-Operating Expenses | Operating Income | -11.2M | 11.0M | -10.0M | -5.0M | |
| Interest Expense On Debt | 5.9M | 2.4M | 234.0K | 236.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -16.5M | 9.1M | -9.7M | -4.7M | |
| Net Income | -16.5M | 9.1M | -9.7M | -4.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 33.0M | 33.3M | 33.3M | 33.4M | |
| Shares To Calculate EPS Diluted | 33.0M | 33.8M | 33.3M | 33.4M | ||
| Earnings Per Share | EPS | -$0.50 | $0.27 | -$0.29 | -$0.14 | |
| EPS Diluted | -$0.50 | $0.27 | -$0.29 | -$0.14 | ||
